Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
The feature you requested does not exist. However, we suggest the following feature:

UK Minister Warns EU Against 'Vaccine Nationalism' Amid Potential Dispute Over Supplies

01/26/2021 | 04:56am EST


© MT Newswires 2021
All news about PFIZER INC.
04:56aUK Minister Warns EU Against 'Vaccine Nationalism' Amid Potential Dispute Ove..
MT
04:02aPFIZER : COVID-19 vaccine slated for possible approval next week
AQ
03:58aHong Kong Stocks Retreat from 31-Month High; E-Star Commercial Gains 4% in De..
MT
02:46aGermany backs EU export restrictions on vaccine after supply cuts
RE
02:41aCOVID : Uk vaccine minister zahawi says very confident of getting uk supply of p..
RE
02:24aCOVID : Uk vaccine minister zahawi says very confident that pfizer will deliver ..
RE
12:28aItaly Writes Formal Letter to Pfizer Over COVID-19 Vaccine Delays
MT
12:11aEU : Pfizer, Other COVID-19 Vaccine Makers Requires Notification Before Exportin..
MT
01/25BioNTech-Pfizer COVID-19 Vaccine Supplies to UK in Q1 Remain Unchanged
MT
01/25Saudi Arabia to get 3 mln AstraZeneca shots in about a week from India
RE
More news
Financials (USD)
Sales 2020 48 000 M - -
Net income 2020 19 801 M - -
Net Debt 2020 43 412 M - -
P/E ratio 2020 12,0x
Yield 2020 3,91%
Capitalization 207 B 207 B -
EV / Sales 2020 5,22x
EV / Sales 2021 4,30x
Nbr of Employees 88 300
Free-Float 59,1%
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 41,71 $
Last Close Price 37,28 $
Spread / Highest target 42,2%
Spread / Average Target 11,9%
Spread / Lowest Target -3,43%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Suzanne Nora Johnson Independent Director
Helen H. Hobbs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.1.28%207 217
JOHNSON & JOHNSON5.46%436 949
ROCHE HOLDING AG3.82%309 894
NOVARTIS AG2.96%220 401
MERCK & CO., INC.-0.79%205 312
ABBVIE INC.3.13%195 085